International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving healthRead more
Research Interest: Mathematical Modeling of Cancer, differential equations, mathematical oncology, mathematical modeling of Immunotherapy.
Research Interest: His interests in liver fibrosis research focuses on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. His immunological interest lies with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy.
Research Interest: I.Cancer prevention programes i.e Cancer Awareness camps &Early detection of cancer. 2.Epidemiological studies on Breast cancer &Cervical cancer
Research Interest: Immunophenotyping, Immunocytochemistry, Multilineag differentiation, RNA isolation, RT- PCR, Cancer cell line, Immunocytochemistry, Real-Time PCR, Western blot, Transport mechanism by liquid santillation Counter, Induction of leukemia in experimental animal, Biochemical enzymatic analysis, TEM analysis, Histopathology, RT-PCR, apoptosis analysis, Western blot, MTT assay, Measurement of intracellular ROS, Analysis of mitochondrial membrane potential, Intracellular calcium levels, Quantiﬁcation of endogenous GSH, DNA fragmentation, Column Chromatography, Antibiotic sensitivity assay, Extract preparation, Antibiotic sensitivity assay
Research Interest: Oral Sciences, Oral Pathology, Molecular Biology, Cancer Biology, Histochemistry
Research Interest: RNA interefence, Immunotherapy and Immunodiagnostics
Research Interest: Brain cancer immunotherapy, Molecular Bio-Chemistry Neuroscience
Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.
Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles
Research Interest: Tumour Microenvironment and Translational Cancer Medicine
Combination of cancer target therapy and immunotherapy
Tumour associated macrophages
Notch signalling in cancer biology
Tumour resistance to target therapy and immunotherapy
Hypoxia and angiogenesis pathways in cancer biology
MicroRNAs in cancer target therapy and immunotherapy
Experimental mouse tumour models
Research interests: Carcinoma Unknown Primary Cancer of Unknown Primary (CUP) is the term applied to metastatic cancer of which the origin remains unidentified. Since treatment is usually based on the profile of the primary cancer, treatment of these patients is a challenge. Reports on incidence, treatment, and survival are limited. My personal challenge is to increase the awareness with regard to CUP via research and support patients suffering from CUP, as well as the patients' family and friends. Prostate cancer. Prostate cancer is a disease of elderly males. An increase in prostate cancer is expected in the coming years due to a growing population of men aged over 60 years of age from 475 million in 2009 to 1.6 billion in the year 2050 worldwide. Moreover, if screening for prostate cancer is taken into account, even more men will be diagnosed with this disease. Immunotherapy, especially the role of Interleukin 7 and TGFbeta
Research Interest: Gut microbiology; Metabolic diseases; Mucosal Immunology; Cancer; Functional foods and Nutraceutical
Research Interest: Molecular mechanisms and signaling pathways underlying cancer progressi on, metastasis and chem resistance
Research Interest: Molecular biology, cytogenetics, genotoxicity, micronucleus, cytome assay, mutagenicity tests, gene expression, human cancer, pituitary adenomas, obesity.
Research Interest: Molecular Biology/Cancer Biology
Published On: April 17, 2017 | Pages: 019 - 031View Article DOI: 10.17352/2455-8591.000015
Published On: March 31, 2017 | Pages: 015 - 018View Article DOI: 10.17352/2455-8591.000014
Published On: February 03, 2017 | Pages: 012 - 014View Article DOI: 10.17352/2455-8591.000013
Published On: February 01, 2017 | Pages: 007 - 011View Article DOI: 10.17352/2455-8591.000012
Published On: February 01, 2017 | Pages: 001 - 006View Article DOI: 10.17352/2455-8591.000011
Published On: December 31, 2016 | Pages: 014 - 016View Article DOI: 10.17352/2455-8591.000010
Published On: October 06, 2016 | Pages: 011 - 013View Article DOI: 10.17352/2455-8591.000009
Published On: June 17, 2016 | Pages: 003 - 010View Article DOI: 10.17352/2455-8591.000008
Published On: January 23, 2016 | Pages: 001 - 002View Article DOI: 10.17352/2455-8591.000007
Published On: October 28, 2015 | Pages: 021 - 028View Article DOI: 10.17352/2455-8591.000006